Roche’s Gazyva Approved in the U.S. – Analyst Blogby Bob MitchellNovember 8, 2013April 17, 2021Roche ( RHHBY ) is a leader in oncology drugs with strong demand for breast cancer drugs like Herceptin, Perjeta …read more